Induction of potent NK cell-dependent anti-myeloma cytotoxic T cells in response to combined mapatumumab and bortezomib.
about
Synergistic Effects of Cabozantinib and EGFR-Specific CAR-NK-92 Cells in Renal Cell Carcinoma.Monoclonal Antibody Therapies for Hematological Malignancies: Not Just Lineage-Specific Targets.Suppression of SOCS3 enhances TRAIL-induced cell growth inhibition through the upregulation of DR4 expression in renal cell carcinoma cells
P2860
Induction of potent NK cell-dependent anti-myeloma cytotoxic T cells in response to combined mapatumumab and bortezomib.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Induction of potent NK cell-de ...... ed mapatumumab and bortezomib.
@ast
Induction of potent NK cell-de ...... ed mapatumumab and bortezomib.
@en
type
label
Induction of potent NK cell-de ...... ed mapatumumab and bortezomib.
@ast
Induction of potent NK cell-de ...... ed mapatumumab and bortezomib.
@en
prefLabel
Induction of potent NK cell-de ...... ed mapatumumab and bortezomib.
@ast
Induction of potent NK cell-de ...... ed mapatumumab and bortezomib.
@en
P2093
P2860
P50
P1433
P1476
Induction of potent NK cell-de ...... ed mapatumumab and bortezomib.
@en
P2093
Alex J Davenport
Andy K Hsu
Camilla A Lindqvist-Gigg
David S Ritchie
H Miles Prince
Heloise M Halse
Joanna Loh
Joanne Davis
Josh Noske
Kate Fielding
P2860
P304
P356
10.1080/2162402X.2015.1038011
P577
2015-05-27T00:00:00Z